Metagenomi Therapeutics Inc (MGX) Price Prediction & ForecastMGXMetagenomi Therapeutics Inc

Alphio's MGX stock price prediction model matches the current Metagenomi Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.16 (-2.75%). The 1-week path is $1.17 (-1.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Metagenomi Inc is not a good buy right now due to significant financial losses and negative performance trends. The current price is $1.19, with a year-to-date change of -28.74% and a 1-year change of -34.62%. Additionally, the RSI is at 35.391, indicating potential oversold conditions but also reflecting weak momentum. The main risk is the ongoing net losses, with the latest reported net income at -$27,482,000 for Q2 2026, which raises concerns about the company's financial stability.

Metagenomi Therapeutics Inc (MGX) last closed at $1.19, losing -1.65%. These facts feed the 1-day and 1-week MGX price prediction above.